The existence of CSCs in breast cancer was first brought to light when it was found that the CD44+CD24−/lowLin− cells from breast cancer patients were able to generate tumors more efficiently than CD44+CD24+Lin− cells when implanted into the mammary fat pads of NOD/SCID mice [4]. The gene discussed is CD24; the disease is breast carcinoma.